CD66c Antibody, anti-human, Biotin, REAfinity™ 130-106-302 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD66c Antibody, anti-human, Biotin, REAfinity™

The CD66c Antibody, anti-human, Biotin, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to CEA cell adhesion molecule 6, and CEACAM6. This antibody recognizes Human antigen. The CD66c Antibody, anti-human, Biotin, REAfinity™ has been validated for the following applications: Flow Cytometry.

Product Specs
ItemCD66c Antibody, anti-human, Biotin, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-106-302
Quantity100 tests in 1 mL
ApplicationsFlow cytometry
Conjugate/TagBiotin
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
TargetCD66c
IsotypeIgG1
CloneREA414
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene NameCEA cell adhesion molecule 6
NCBI Gene AliasesCD66c, CEAL, NCA
Clonalitymonoclonal
Regulatory StatusFor research use only
Concentration1:11
ModificationsRecombinantly engineered
Research AreaFor research use only

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Significance of CD66c expression in childhood acute lymphoblastic leukemiaLeukemia researchJanuary 1, 2014Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, et al.

(2) CD66c expression in B-cell acute lymphoblastic leukemia: strength and weaknessInternational journal of laboratory hematologyFebruary 1, 2011Guillaume N, Penther D, Vaida I, Gruson B, Harrivel V, Claisse JF, Capiod JC, Lefrere JJ, Damaj G.

(3) Characterization of a cDNA clone for the nonspecific cross-reacting antigen (NCA) and a comparison of NCA and carcinoembryonic antigenThe Journal of biological chemistryMarch 5, 1988Neumaier M, Zimmermann W, Shively L, Hinoda Y, Riggs AD, Shively JE.

Be the First to Write a Review!